This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Can Sustained Strength in Water Drive ECL Stock Before Q4 Earnings?
by Zacks Equity Research
Ecolab's Water and Pest segments show solid momentum ahead of fourth-quarter 2025 results, but Paper weakness and macro uncertainty could temper overall growth.
ECLPositive Net Change ESINegative Net Change LINPositive Net Change GVDNYPositive Net Change
earnings medical medical-devices
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
by Zacks Equity Research
VEEV's strong Q3, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.
BSXNegative Net Change IDXXPositive Net Change STENegative Net Change VEEVNegative Net Change
medical medical-devices
GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
by Zacks Equity Research
GEHC tops Q4 EPS and revenue estimates as Imaging and PDx drive growth, but net margin slides on tariffs and product mix.
BSXNegative Net Change ATRCPositive Net Change PAHCPositive Net Change GEHCPositive Net Change
earnings medical medical-devices
The Zacks Analyst Blog Highlights Alphabet, Apple, Thermo Fisher Scientific and New England Realty Associates
by Zacks Equity Research
Alphabet leads today's Analyst Blog as AI-driven cloud growth, search innovation, and strong adoption fuel outperformance versus peers.
AAPLPositive Net Change TMONegative Net Change GOOGLPositive Net Change NENNo Net Change
computers finance internet medical-devices
Northwest Bancshares (NWBI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NWBIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Pathward Financial (CASH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CASHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?
by Zacks Equity Research
CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.
CAHPositive Net Change CVSNegative Net Change MMSIPositive Net Change VCYTNegative Net Change
earnings medical medical-devices
Top Analyst Reports for Alphabet, Apple & Thermo Fisher
by Mark Vickery
Alphabet headlines Zacks' top analyst reports as AI-driven growth in Cloud, Search and YouTube powers strong stock outperformance.
BANegative Net Change AAPLPositive Net Change NDAQPositive Net Change WDCPositive Net Change TMONegative Net Change GOOGLPositive Net Change NENNo Net Change
computers finance internet medical-devices
Reasons to Add Cooper Companies Stock to Your Portfolio Now
by Zacks Equity Research
COO is riding premium MyDay lens momentum and margin expansion plans, but Asia-Pacific softness, tariffs and mix pressures pose near-term risks.
ISRGPositive Net Change CAHPositive Net Change COOPositive Net Change WSTNegative Net Change
medical medical-devices
GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut
by Zacks Equity Research
GE HealthCare's Allia Moveo wins FDA and CE clearance, enabling commercialization of a mobile C-arm with AI guidance, compact design and early global installs.
BSXNegative Net Change ATRCPositive Net Change VCYTNegative Net Change GEHCPositive Net Change
medical medical-devices